Earnings Recaps

Browse reported earnings of the most popular stocks

Sep 19, 2026 Sep 18, 2026 Sep 17, 2026 Sep 16, 2026 Sep 14, 2026 Sep 13, 2026 Sep 12, 2026 Sep 11, 2026 Sep 10, 2026 Sep 9, 2026 Sep 8, 2026 Sep 5, 2026 Sep 4, 2026 Sep 3, 2026 Sep 2, 2026 Sep 1, 2026 Aug 31, 2026 Aug 30, 2026 Aug 29, 2026 Aug 28, 2026 Aug 27, 2026 Aug 26, 2026 Aug 25, 2026 Aug 23, 2026 Aug 22, 2026 Aug 21, 2026 Aug 20, 2026 Aug 19, 2026 Aug 18, 2026 Aug 17, 2026 Aug 16, 2026 Aug 15, 2026 Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026
10 companies Today

Baidu, Inc.

BIDU Q2 2026
Reported: 2026-08-20

Baidu’s shares fell 10.8% post-earnings as investors reacted negatively to a cautious outlook that overshadowed strong AI Cloud Infra growth, signaling concerns about the company’s overall future momentum and margin sustainability.

Key takeaways
  • AI Cloud Infra revenue grew 50% year-over-year, with GPU Cloud revenue accelerating to 283% growth, highlighting strong demand for scalable AI compute services.
  • Proprietary AI chips, Kunlunxin, saw broadening industry adoption and enhanced compatibility with major Chinese foundation models, supporting future AI infrastructure expansion.
  • AI Cloud Infra margins expanded year-over-year, driven by a shift toward higher-quality, GPU Cloud revenue with more attractive profitability.
  • Despite strong execution in AI Cloud and chip segments, market reaction suggests investor concerns about deceleration or uncertainty in other business segments or the company’s outlook.
  • External customer token usage on the MaaS platform grew more than ninefold year-over-year, indicating strong user engagement with Baidu’s AI model services.

Coloplast A/S

CLPBY Q3 2026
Reported: 2026-08-20

Shares rose 6.1% as Coloplast reassured investors with sustained leadership positions, a strong product portfolio, and clear strategic priorities to drive growth, particularly emphasizing growth potential in the U.S. market.

Key takeaways
  • Chronic Care remains the core segment, representing over 75% of sales, with continued leadership and an annuity-based business model reinforcing revenue stability.
  • U.S. market highlighted as a significant growth opportunity, currently under-penetrated with market shares of 15-20% in Ostomy Care and about 30% in Continence Care.
  • Biologics segment in Wound & Tissue Repair faces challenges due to a recent U.S. market reset but focusing on inpatient care and clinical differentiation to restore profitable growth.
  • New CEO Gavin Wood is prioritizing disciplined capital allocation, investment governance, and innovation pipeline to accelerate growth and extend competitive moats.
  • Leadership changes include appointing a new Chief People Officer and executive realignment in Wound & Tissue Repair to strengthen organizational focus and execution.

Elopak ASA

ELO.OL Q2 2026
Reported: 2026-08-20

Elopak shares fell 4.1% as investors reacted negatively to ongoing margin pressure from higher raw material costs and supply constraints following a key supplier incident in the Americas, leading to a deceleration in top-line growth and cautious outlook for the region.

Key takeaways
  • Revenue grew 4.9% (5.7% constant currency), driven by 8.7% growth in Americas and 8% carton and closure growth in EMEA, though Americas growth is slowing due to supply disruptions.
  • Adjusted EBITDA margin compressed to 14.8%, impacted by raw material cost inflation that outpaced implementation of customer surcharges in Q2.
  • Supply chain constraints caused by a major supplier’s operational shutdown in Washington have disrupted Americas growth momentum and will impact near-term performance.
  • Management expects margin recovery in Q3 from surcharges but remains cautious on Americas outlook amid ongoing market and geopolitical uncertainties.
  • The dividend declared remains consistent with policy, signaling confidence in the balance sheet despite current operational challenges.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...